December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Can Nasal Ischaemia Predict Proliferative Retinopathy in Type 2 Diabetes?
Author Affiliations & Notes
  • GC Vafidis
    Department of Ophthalmology GKT Rayne Institute London United Kingdom
  • JV Arnold
    Eye Department Central Middlesex Hospital London United Kingdom
  • AM Hamilton
    Department of Ophthalmology GKT Rayne Institute London United Kingdom
  • Footnotes
    Commercial Relationships   G.C. Vafidis, None; J.V. Arnold, None; A.M. Hamilton, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3860. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      GC Vafidis, JV Arnold, AM Hamilton; Can Nasal Ischaemia Predict Proliferative Retinopathy in Type 2 Diabetes? . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3860.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To define arc-pattern nasal retinal ischaemia on fluorescein angiography (FFA) and explore its temporal relationship with development of proliferative diabetic retinopathy (PDR) Methods: We analysed FFA of 30 Type 2 diabetic eyes with peripheral retinal ischaemia in 4 quadrants. Areas of ischaemia were identified when crossing arterioles and venules stained in late-venous phase angiograms. Tracing disc and main vessels on to overlaid acetate sheets created a retinal montage of each eye and the posterior limit of vessel staining was marked on the montage. This produced a centripetal arc-pattern around the disc in the nasal retina. The anterior limit of the arc was marked if present. The best fit 'centre' of the posterior arc was determined by comparison with overlaid concentric circles and distance from arc to nasal disc was measured in disc diameters (dd). The onset of subsequent PDR in these eyes was determined from clinical records. Results: All eyes that developed PDR within a year of the FFA date (n=8) had nasal retinal ischaemia almost up to (<1dd) the disc margin. Those developing PDR within 1-2years (n=11) had 1-2dd of nasal retina between posterior limit of ischaemia and disc and in both these groups the arc-pattern centred on the optic disc. One eye developed PDR after 4 years' follow up with 2+ dd arc distance. In the remainder (n=10), PDR had not developed an average of 1.7 years (range 1-4y) since the FFA. Although the majority had arc distances 1 - 2dd from the disc, 3 of these non-proliferative eyes had ischaemia within1dd of the nasal disc margin. Conclusion: We report an observed trend between proximity of retinal ischaemia to the nasal disc margin and onset of PDR in Type 2 diabetes. If this simple formula were to be validated by larger numbers, it would be a useful guide for planning prophylactic and macular laser treatment. Although the majority of eyes examined conformed to the observed trend, the exceptions warrant further analysis to try to identify local and systemic features that may have delayed onset of PDR.

Keywords: 448 ischemia • 523 proliferation • 388 diabetic retinopathy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.